Invention Grant
US08530466B2 Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis
有权
使用2,4-嘧啶二胺治疗动脉粥样硬化
- Patent Title: Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis
- Patent Title (中): 使用2,4-嘧啶二胺治疗动脉粥样硬化
-
Application No.: US12867928Application Date: 2009-02-20
-
Publication No.: US08530466B2Publication Date: 2013-09-10
- Inventor: Esteban Masuda , Jochen Schmitz
- Applicant: Esteban Masuda , Jochen Schmitz
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- International Application: PCT/US2009/034718 WO 20090220
- International Announcement: WO2009/105675 WO 20090827
- Main IPC: A61K31/535
- IPC: A61K31/535
Abstract:
Novel methods and compositions for the prevention and treatment of all forms of atherosclerosis with 2,4-pyrimidinediamine compounds are described. Also disclosed is the coating of prosthetic devices, such as stents, with the compounds of the invention for the prevention and/or treatment of restenosis.
Public/Granted literature
- US20110046126A1 Use of 2,4-Pyrimidinediamines For the Treatment of Atherosclerosis Public/Granted day:2011-02-24
Information query
